These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1611135)

  • 1. Relationship of lipid peroxides to diabetic complications. Comparison with conventional laboratory tests.
    Armstrong D; Abdella N; Salman A; Miller N; Rahman EA; Bojancyzk M
    J Diabetes Complications; 1992; 6(2):116-22. PubMed ID: 1611135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular complications of patients in Kuwait with type 2 diabetes mellitus (NIDDM) and elevated serum lipid peroxides.
    Lanham RJ; Armstrong D; Abdella N
    Adv Exp Med Biol; 1994; 366():433-5. PubMed ID: 7771283
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications.
    Kesavulu MM; Giri R; Kameswara Rao B; Apparao C
    Diabetes Metab; 2000 Nov; 26(5):387-92. PubMed ID: 11119018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible relevance of lipid peroxidation and thromboxane production to the initiation and/or evolution of microangiopathy in non-hyperlipidemic type 2 diabetes mellitus.
    Katoh K
    Diabetes Res Clin Pract; 1992 Nov; 18(2):89-98. PubMed ID: 1478157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of authentic plasma hydroperoxides in NIDDM.
    Nourooz-Zadeh J; Tajaddini-Sarmadi J; McCarthy S; Betteridge DJ; Wolff SP
    Diabetes; 1995 Sep; 44(9):1054-8. PubMed ID: 7657028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of lipid peroxides to macrovascular disease in type 2 diabetes.
    Velázquez E; Winocour PH; Kesteven P; Alberti KG; Laker MF
    Diabet Med; 1991 Oct; 8(8):752-8. PubMed ID: 1838067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated plasma levels of transforming growth factor-beta 1 in NIDDM.
    Pfeiffer A; Middelberg-Bisping K; Drewes C; Schatz H
    Diabetes Care; 1996 Oct; 19(10):1113-7. PubMed ID: 8886558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of serum total sialic acid concentrations with diabetic complications and cardiovascular risk factors in Kuwaiti Type 2 diabetic patients.
    Abdella N; Akanji AO; Mojiminiyi OA; Al Assoussi A; Moussa M
    Diabetes Res Clin Pract; 2000 Sep; 50(1):65-72. PubMed ID: 10936670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of diabetic retinopathy and nephropathy in Polynesians of Western Samoa.
    Collins VR; Dowse GK; Plehwe WE; Imo TT; Toelupe PM; Taylor HR; Zimmet PZ
    Diabetes Care; 1995 Aug; 18(8):1140-9. PubMed ID: 7587849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
    Chow CC; Tsang LW; Sorensen JP; Cockram CS
    Diabetes Care; 1995 Mar; 18(3):307-14. PubMed ID: 7555472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
    Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
    Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in thiobarbituric acid-reactive substances and vascular complications in type 2 diabetes mellitus.
    Gallou G; Ruelland A; Campion L; Maugendre D; Le Moullec N; Legras B; Allannic H; Cloarec L
    Diabete Metab; 1994; 20(3):258-64. PubMed ID: 8001713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes.
    Yang CY; Su PF; Hung JY; Ou HT; Kuo S
    Cardiovasc Diabetol; 2020 Jul; 19(1):105. PubMed ID: 32631323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular complications in long-term south Indian NIDDM of over 25 years' duration.
    Mohan V; Vijayaprabha R; Rema M
    Diabetes Res Clin Pract; 1996 Mar; 31(1-3):133-40. PubMed ID: 8792113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum sialic acid concentration in NIDDM and its relationship to blood pressure and retinopathy.
    Crook MA; Tutt P; Pickup JC
    Diabetes Care; 1993 Jan; 16(1):57-60. PubMed ID: 8422833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiobarbituric acid test as a measure of lipid peroxidation in Arab patients with NIDDM.
    Abdella N; al Awadi F; Salman A; Armstrong D
    Diabetes Res; 1990 Dec; 15(4):173-7. PubMed ID: 2132405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of oxidative stress to thrombotic tendency in type 1 diabetic patients with retinopathy.
    Jennings PE; McLaren M; Scott NA; Saniabadi AR; Belch JJ
    Diabet Med; 1991 Nov; 8(9):860-5. PubMed ID: 1837513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus.
    Ak G; Buyukberber S; Sevinc A; Turk HM; Ates M; Sari R; Savli H; Cigli A
    J Diabetes Complications; 2001; 15(3):150-7. PubMed ID: 11358684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects.
    Nakano S; Fukuda M; Hotta F; Ito T; Ishii T; Kitazawa M; Nishizawa M; Kigoshi T; Uchida K
    Diabetes; 1998 Sep; 47(9):1501-6. PubMed ID: 9726241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy.
    Nielsen FS; Voldsgaard AI; Gall MA; Rossing P; Hommel E; Andersen P; Dyerberg J; Parving HH
    Diabetologia; 1993 May; 36(5):438-44. PubMed ID: 8314449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.